Urology Doctors in Olathe, KS Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Dr. Jason William Anast, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St Ste 409, Olathe, KS 66061 Phone: 913-780-3388    Fax: 913-780-3256

Howard Chris Halvorson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 10569 S Glenview Ln, Olathe, KS 66061 Phone: 913-486-4241    Fax: 913-764-4114

Anton Galich, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St Ste 270, Olathe, KS 66061 Phone: 913-780-3388    Fax: 913-780-3256

Mirian Boci, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St Ste 409, Olathe, KS 66061 Phone: 913-780-3388    Fax: 913-780-3256

News Archive

Highlights: Fla. restaurant's health law surcharge; Fla. faces ER Medicaid fines; early-elective deliveries drop

A selection of health policy stories from Florida, California, the District of Columbia, Pennsylvania and Wisconsin.

Elekta receives EU CE marking for Connexion modular couchtop

Elekta's Connexion modular couchtop is CE marked and successfully released for sale in the European Union. Connexion meets the clinic's need to tailor patient set-up to accommodate the unique therapy requirements of the individual patient.

Huntington's disease prevention breakthrough? An interview with Professor Lesley Jones

Huntington's disease is an inherited disease which, whilst quite rare, is one of the more common inherited neurodegenerative diseases. About 1 in 6,000 people in the UK are at risk and what's horrible about this disease is that if one of your parents has it, then you have a fifty-fifty chance of inheriting it.

Psychiatric Times focuses on helping clinicians treat people with personality disorders

UBM Medica today announced that Psychiatric Times features special coverage focused on helping mental health professionals treat people with various types of personality disorders.

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe hypertension. The product will be available in two vial sizes – 100 mg per 20 mL and 200 mg per 40 mL, multi-dose vials.

Read more Medical News

› Verified 6 days ago